logo

Biomarin Pharmaceutical Inc. (BMRN)



Trade BMRN now with
  Date
  Headline
3/1/2019 7:32:46 AM BioMarin Receives Positive CHMP Opinion In Europe For Palynziq
2/26/2019 7:55:17 AM Wedbush Is Cutting Biomarin Pharmaceutical Inc. (BMRN) FY20 Rev. Estimate To 1940 M From 2002 M
2/26/2019 7:55:05 AM Wedbush Is Lowering Biomarin Pharmaceutical Inc. (BMRN) Q4 20 Rev. Estimate To 519.1 M From 528.3 M
2/26/2019 7:54:52 AM Wedbush Is Lowering Biomarin Pharmaceutical Inc. (BMRN) Q3 20 Rev. Estimate To 496.0 M From 508.2 M
2/26/2019 7:54:37 AM Wedbush Is Cutting Biomarin Pharmaceutical Inc. (BMRN) Q2 20 Rev. Estimate To 472.6 M From 495.4 M
2/26/2019 7:54:22 AM Wedbush Is Cutting Biomarin Pharmaceutical Inc. (BMRN) Q1 20 Rev. Estimate To 452.4 M From 470.2 M
2/26/2019 7:53:45 AM Wedbush Is Cutting Biomarin Pharmaceutical Inc. (BMRN) FY19 Rev. Estimate To 1682 M From 1738 M
2/26/2019 7:53:32 AM Wedbush Is Lowering Biomarin Pharmaceutical Inc. (BMRN) Q4 19 Rev. Estimate To 452.5 M From 459.7 M
2/26/2019 7:53:15 AM Wedbush Is Cutting Biomarin Pharmaceutical Inc. (BMRN) Q3 19 Rev. Estimate To 431.1 M From 439.3 M
2/26/2019 7:53:03 AM Wedbush Is Lowering Biomarin Pharmaceutical Inc. (BMRN) Q2 19 Rev. Estimate To 414.0 M From 431.7 M
2/26/2019 7:52:51 AM Wedbush Is Cutting Biomarin Pharmaceutical Inc. (BMRN) Q1 19 Rev. Estimate To 384.8 M From 407.2 M
2/26/2019 7:45:20 AM Wedbush Is Cutting Biomarin Pharmaceutical Inc. (BMRN) FY20 Estimate To 0.40 From 1.13
2/26/2019 7:45:04 AM Wedbush Is Lowering Biomarin Pharmaceutical Inc. (BMRN) Q4 20 Estimate To 0.19 From 0.36
2/26/2019 7:43:59 AM Wedbush Is Cutting Biomarin Pharmaceutical Inc. (BMRN) Q3 20 Estimate To 0.13 From 0.30
2/26/2019 7:43:48 AM Wedbush Is Cutting Biomarin Pharmaceutical Inc. (BMRN) Q2 20 Estimate To 0.07 From 0.27
2/26/2019 7:43:35 AM Wedbush Is Cutting Biomarin Pharmaceutical Inc. (BMRN) Q1 20 Estimate To 0.01 From 0.20
2/26/2019 7:43:15 AM Wedbush Is Lowering Biomarin Pharmaceutical Inc. (BMRN) FY19 Estimate To -0.46 From 0.41
2/26/2019 7:42:47 AM Wedbush Is Lowering Biomarin Pharmaceutical Inc. (BMRN) Q4 19 Estimate To -0.01 From 0.17